Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hunt

Showing results (781-790 of 1,059) with videos related to

Pageof 106
Sort By:
Cancer Gene Therapy|November 12, 2005
mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family membersS Chada, A M Mhashilkar, Y Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancerJeffrey M Albert, Ana M Gonzalez-Angulo, Merih Guray, et al.
Plastic and Reconstructive Surgery|May 3, 2011
Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapyRanjna Sharma, Loren L Rourke, Steven J Kronowitz, et al.
The Lancet. Oncology|November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapyJacqueline S Jeruss, Elizabeth A Mittendorf, Susan L Tucker, et al.
Cancer|February 6, 2009
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy, Funda Meric-Bernstam, Anthony Lucci, et al.
AJNR. American Journal of Neuroradiology|December 24, 2011
Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniquesK Dolic, K Marr, V Valnarov, et al.
Annals of Surgical Oncology|January 1, 1997
Transduction of murine and human tumors using recombinant adenovirus vectorsE M Toloza, K Hunt, A R Miller, et al.
Cancer|February 29, 2008
Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomasWaddah B Al-Refaie, Robert H I Andtbacka, Joe Ensor, et al.
Pageof 106

Showing results (781-790 of 1,059) with videos related to

Sort By:
Pageof 106
Cancer Gene Therapy|November 12, 2005
mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family membersS Chada, A M Mhashilkar, Y Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancerJeffrey M Albert, Ana M Gonzalez-Angulo, Merih Guray, et al.
Plastic and Reconstructive Surgery|May 3, 2011
Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapyRanjna Sharma, Loren L Rourke, Steven J Kronowitz, et al.
The Lancet. Oncology|November 19, 2013
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2007
Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapyJacqueline S Jeruss, Elizabeth A Mittendorf, Susan L Tucker, et al.
Cancer|February 6, 2009
A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancerSavitri Krishnamurthy, Funda Meric-Bernstam, Anthony Lucci, et al.
AJNR. American Journal of Neuroradiology|December 24, 2011
Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniquesK Dolic, K Marr, V Valnarov, et al.
Annals of Surgical Oncology|January 1, 1997
Transduction of murine and human tumors using recombinant adenovirus vectorsE M Toloza, K Hunt, A R Miller, et al.
Cancer|February 29, 2008
Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomasWaddah B Al-Refaie, Robert H I Andtbacka, Joe Ensor, et al.
Pageof 106